Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2025-12-25 @ 1:20 AM
NCT ID:
NCT01169493
Eligibility Criteria:
Inclusion Criteria:
* Cardiomyopathy of either idiopathic or ischemic etiology
* NYHA class III, or IV symptoms
* Sinus rhythm
* QRS complex duration \> 130 msec in ≥ 2 surface ECG leads with RBBB
* PR interval \> 150 msec and \< 240 msec
* Prior implantation of dual chamber BiV ICD with apical RV lead location
Exclusion Criteria:
* Myocardial infarction, major surgical procedure, or acute cardiac failure crisis requiring inotropes within 6 months of entry into the study
* Atrial fibrillation or flutter lasting \>12 hours within the last 6 months
* Sick sinus syndrome, complete heart block, or other arrhythmias requiring pacemaker support
* Pregnancy
* Any other known condition other than heart failure that could limit exercise time or survival to \< 6 months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01169493
Study Brief:
Protocol Section:
NCT01169493